AzTrials
AzTrials

Apical PeriodontitisNCT03743987

The Effect of MTA and PRF Application in Periapical Lesions

A study testing MTA group, PRF group and MTA + PRF group in people with Apical Periodontitis and Wound Heal, run by Recep Tayyip Erdogan University Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A total of 40 periapical lesions from the 33 patient undergoing apical surgery were randomly selected from December 2016-November 2017. Patients were informed about the surgical procedure and signed a consent form. Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Apical Periodontitis, Wound Heal
What is being tested?
MTA group, PRF group and MTA + PRF group
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
36 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Dec 2016to 5 Nov 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Single rooted canals
  • Failed previous root canal treatment
  • Retreatment at least 1 year previously
  • Previous surgery with unresolved bony lesion

Who cannot join

  • More than single rooted canals
  • Chronic generalized periodontitis
  • Any systemic disease contraindicating oral surgical procedures
  • Evidence of root fracture
  • Resorptive processes involving more than apical third of the root

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Nazife Begüm KARAN

    Ankara, Merkez, 83TR2WATUF

Other trials in Turkey (Türkiye)

About this study

Official title: Assessment of Bone Healing After MTA and PRF Application in Periapical Lesions By Using CBCT

A total of 40 periapical lesions from the 33 patient undergoing apical surgery were randomly selected from December 2016-November 2017. Patients were informed about the surgical procedure and signed a consent form. Groups were divided in to 4; as control, MTA (mineral trioxide aggregate), PRF (platelet rich fibrin) and MTA+PRF groups. Apical resection was performed in all groups. No other interventions were made to the control group.

Routine radiographs were taken in the 1st. 3th and 6th months. In the (approximately) 12th month of the procedures computerized tomography scans were taken. Primary healing of the periapical tissues were evaluated and the outcomes were measured. Patients have still been under control for the long term outcomes of the study.

Read the detailed description

44 apically infected periapical lesions were decided to enroll to the study from December 2016-November 2017. However; a total of 40 periapical lesions undergoing apical surgery were recruited for the planned clinical trial in the end. The study was conducted under randomized controlled protocol. Patients were informed about the surgical procedures and signed a consent form. The anticipated outcomes, possible risks and benefits of the study as well as the alternative treatment options were explained to the patients.

Groups were designed to have 10 patients in each and randomly divided into four as; control, MTA, PRF and MTA+PRF. Apical resection was performed in all groups. No other interventions were made to the control group.

Routine radiographs were taken in the 1st. 3th and 6th months. In the 12th month of the procedures computerized tomography (CT) scans were taken. Primary healing of the periapical tissues were evaluated according to the volumes and the densities of the lesions. Outcomes were measured. Comparison between the initial and the last 3D CT scan volumes were made by medical image processing software (MIMICS, Belgium). Patients have still been under control for the long term outcomes of the study.

Being tested
control group, MTA group, PRF group, MTA + PRF group
Medical subject headings
Periapical Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • control groupProcedure or surgery

    Also called root resection

    a procedure used to prevent or resolves apical periodontitis.

  • MTA groupProcedure or surgery

    Also called mineral trioxide aggregate

    a procedure used to prevent or resolves apical periodontitis.

  • PRF groupProcedure or surgery

    Also called platelet rich fibrin

    a procedure that is used for wound healing

  • MTA + PRF groupProcedure or surgery

    Also called mineral trioxide aggregate + mineral trioxide aggregate

    a procedure used to prevent or resolves apical periodontitis in combination with a procedure that is used for wound healing.

Study groups in NCT03743987
Study groupRoleWhat they receive
control groupSham comparatorApical resection group. Only root resection was applied without any other interventions (like prf or mta)
Receives: Procedure: control group
MTA groupExperimentalRoot resection was applied and MTA was inserted through the apical foramen
Receives: Procedure: MTA group
PRF groupExperimentalRoot resection was applied and PRF was placed to the surgically prepared area
Receives: Procedure: PRF group
MTA + PRF groupExperimentalRoot resection was applied. MTA was inserted through the apical foramen and PRF was placed to the surgically prepared area
Receives: Procedure: MTA + PRF group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Radiographic success - in volume

    Evaluation of tomographic outcomes (differences between preoperative and postoperative volume of periapical lesions)

    Measured: 1 year

  2. Radiographic success - in density

    Evaluation of tomographic outcomes (differences between preoperative and postoperative density of periapical lesions)

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Nov 2018
  2. Study start20 Dec 2016
  3. Primary completion5 Nov 2018
  4. Study completion5 Nov 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03743987
Sponsor's protocol ID
RTEU 107
Status last verified
Feb 2019
First submitted
14 Nov 2018
Last updated
25 Feb 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: data can be available 6 months after the acceptance of the paper

Publications

  • Karan NB, Aricioglu B. Assessment of bone healing after mineral trioxide aggregate and platelet-rich fibrin application in periapical lesions using cone-beam computed tomographic imaging. Clin Oral Investig. 2020 Feb;24(2):1065-1072. doi: 10.1007/s00784-019-03003-x. Epub 2019 Jul 18.

    PubMed 31321573

Questions about this trial

What is this clinical trial studying?

A study testing MTA group, PRF group and MTA + PRF group in people with Apical Periodontitis and Wound Heal, run by Recep Tayyip Erdogan University Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Radiographic success - in volume (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03743987, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in